To give potential applicants as much time as possible to form consortia and prepare their proposals, IMI regularly publishes draft topic texts on this page several weeks before the official Call launch. To ensure you get the latest information on forthcoming Calls, sign up to our newsletter, follow us on Twitter, or join our LinkedIn group.
Draft topic texts are subject to consultations involving IMI's States Representatives Group, Scientific Committee, and the European Commission. They must also be approved by the IMI Governing Board. Depending on the results of the consultations and approval process, the final topic text may differ significantly from the draft versions initially published here, and some topics may not be included in a Call in the end.
The following topics are currently under consideration for inclusion in future IMI Calls for proposals:
- Targeted immune intervention for treatment of non-response and remission
- Non-invasive clinical molecular imaging of immune cells
- Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
- Centre of excellence – remote decentralised clinical trials
We encourage the participation of SMEs in our projects. This presentation highlights elements of the current indicative Call topics that could be particularly interesting for SMEs. More information and guidance for SMEs can be found in our dedicated SME section.
All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be communicated after approval by the IMI Governing Board.